NCT03898466
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Asthma Research Lab University of Saskatchewan Room 346 Ellis Hall Saskatoon, Saskatchewan, Canada
Clinical trial condition
Bronchial Diseases
Explore clinical trials studying Bronchial Diseases. Study availability and eligibility vary by location and protocol.
4,808 public trials
452 recruiting studies
Bronchial Diseases trial results
NCT00147082
- Conditions
- Bronchial Diseases, Bronchitis, Bronchitis, Chronic, +13 more
- Locations
-
- Royal Brompton Hospital/NHLI Imperial College London London, United Kingdom
Completed
Leukocyte Function in Asthma and COPD
NCT00147069
- Conditions
- Asthma, Bronchial Diseases, Bronchitis, +18 more
- Locations
-
- Royal Brompton Hospital/NHLI Imperial College London London, United Kingdom
Completed
Asthma and Obstructive Sleep Apnea (OSA)
NCT01026298
- Conditions
- Apnea, Asthma, Bronchial Diseases, +15 more
- Locations
-
- Univeristy of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
Completed
Macrophage Phagocytosis in COPD
NCT00298389
- Conditions
- Bronchial Diseases, Bronchitis, Bronchitis, Chronic, +13 more
- Locations
-
- Imperial College London London, United Kingdom
Completed
Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children
NCT02377427
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +12 more
- Locations
-
- GSK Investigational Site San Diego, California, United States
- GSK Investigational Site Oklahoma City, Oklahoma, United States
- GSK Investigational Site Medford, Oregon, United States
- GSK Investigational Site Madison, Wisconsin, United States
NCT02660853
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Biomedical research Unit, Royal Brompton Hospital, Sydney Street London, United Kingdom
NCT03014674
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Baltimore, Maryland, United States
- GSK Investigational Site Berlin, Germany
- GSK Investigational Site Harrow, Middlesex, United Kingdom
Completed
A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects
NCT02135692
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +12 more
- Locations
-
- GSK Investigational Site Newport Beach, California, United States
- GSK Investigational Site Riverside, California, United States
- GSK Investigational Site Rolling Hills Estates, California, United States
- GSK Investigational Site Denver, Colorado, United States
Completed
Clinical Endpoint Bioequivalence Study of Fluticasone Propionate & Salmeterol Xinafoate (100μg/50μg)
NCT03535870
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- West-Ward Research Site #1 Las Vegas, Nevada, United States